(Q35966781)

11 August 2017

1 reference

title

Hormone replacement therapy in women with spinal cord injury - a survey with literature review (English)

1 reference

Hormone Replacement Therapy

11 August 2017

main subject

1 reference

Khong S

1

1 reference

11 August 2017

Savic G

series ordinal

2

1 reference

11 August 2017

Gardner BP

series ordinal

3

1 reference

11 August 2017

Ashworth F

series ordinal

4

1 reference

11 August 2017

publication date

1 February 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

43

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

67-73

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.sc.3101694

11 August 2017

exact match

0 references

cites work

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Postmenopausal hormone replacement therapy: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Estrogen replacement therapy and protection from acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Postmenopausal oestrogen treatment and stroke: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

A clinical trial of estrogen-replacement therapy after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Estrogen plus progestin and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Breast cancer and hormone-replacement therapy: the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Bone mineral density and indexes of bone metabolism in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Benefits and harms associated with hormone replacement therapy: clinical decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Decision analysis of hormone replacement therapy after the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Effects of estrogen plus progestin on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Fracture rates and risk factors for fractures in patients with spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Long-term survival in spinal cord injury: a fifty year investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Aging bone and osteoporosis: strategies for preventing fractures in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Pharmacotherapy of osteoporosis in postmenopausal women: focus on safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Osteoporosis management in the new millennium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Bisphosphonate treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Bisphosphonates in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Alendronate increases bone density in chronic spinal cord injury: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

The use of intermittent human parathyroid hormone as a treatment for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Supralesional and sublesional bone mineral density in spinal cord-injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Evaluation of a training program for persons with SCI paraplegia using the Parastep 1 ambulation system: part 3. Lack of effect on bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Effect of electrical stimulation-induced cycling on bone mineral density in spinal cord-injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Intensive exercise may preserve bone mass of the upper limbs in spinal cord injured males but does not retard demineralisation of the lower body

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Cyclical etidronate: Its effect on bone density in patients with acute spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Regional osteoporosis in women who have a complete spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Osteoporosis after spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Hospital readmissions in people with chronic spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Osteoporosis in women with spinal cord injuries.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

A multicenter study of women's self-reported reproductive health after spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Effects of tiludronate on bone loss in paraplegic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Effects of functional electrical stimulation-induced lower extremity cycling on bone density of spinal cord-injured patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Increased Bone Mineral Density after Prolonged Electrically Induced Cycle Training of Paralyzed Limbs in Spinal Cord Injured Man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Electrical stimulation: can it increase muscle strength and reverse osteopenia in spinal cord injured individuals?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101694

7 January 2021

Identifiers

DOI

10.1038/SJ.SC.3101694

1 reference

11 August 2017

1 reference